DustinRobertson

@RensingTrades This status is simpler than you lay it out. Yes, you need to be active, but there is no trade number you need to hit. I think it is just trading most days. It is the 475F election and can only be made when you file your taxes. It applies to one account irs.gov/taxtopics/tc429

IF YOU MAKE A LOT OF TRADES PER YEAR STOP AND READ THIS So my CPA told me this year that I would qualify for "Active Trader Status" If you've never heard of it before this can be massive for you and your portfolio when filing taxes... heres a quick breakdown below of how you can qualify and what it can do for you! Active Trader Status (or Trader Tax Status - TTS) is an IRS designation for individuals who trade securities with high volume, frequency, and regularity, allowing them to treat trading as a business. Benefits include deducting expenses on Schedule C (like home office, software, and subscriptions) and potentially electing Mark-to-Market accounting to bypass wash sale rules and the $3,000 capital loss limit Key Requirements to Qualify (Based on IRS & Court Guidelines): Substantial Activity: High volume and frequency, typically interpreted as roughly 720+ trades per year. Continuity/Regularity: Trading on most days the market is open (roughly 4 days/week or 75%+ of market days). Time Commitment: Substantial time dedicated to trading, often considered full-time or nearly so (4+ hours/day). Intent: Aiming to profit from short-term daily market movements, not long-term appreciation or dividends. Average Holding Period: Generally, holding periods should be under 31 days to distinguish from investing. Key Benefits & Considerations: Deduct Expenses: Trading expenses are deductible business expenses (Schedule C), rather than restricted investment expenses. Mark-to-Market (Section 475): Allows traders to treat gains/losses as ordinary income, removing the $3,000 limitation on capital loss deductions. No Wash Sales: Section 475 election exempts traders from the wash sale rule, which otherwise defers losses on similar securities bought within 30 days. How to Apply: There is no official form to request TTS. It is claimed by Filing Schedule C and reporting activity as a business. The MTM election requires a timely election statement by April 15 of the current tax year.

@askOkara If your CMO is focused on SEO, you’re competing for demand. The real job is creating it.

Today we're introducing the world's first AI CMO. Enter your website and it deploys a team of agents to help you get traffic and users. Try it now at okara.ai/cmo

@MaryBschanck @grok can you confirm these patterns happen broadly in biotech?

$SLS I want to share something that stood out to me after reviewing the data and studying how biotech companies tend to behave ahead of major catalysts. Over the last four years (2022–2025), $SLS released 9 press releases each Q1—January through March. That’s 36 PRs across those four years. This isn’t speculation; it’s based on the company’s historical communication pattern. Now look at 2026. We’re already in March, and so far there has been only one official press release. That’s not just a slowdown. That’s a behavioral shift. When a biotech company that normally communicates frequently suddenly becomes very quiet during the final stage of a Phase 3 trial, it can often signal that something significant may be unfolding behind the scenes. Historically, companies sometimes enter quieter periods when approaching major events such as: 1.Final trial readouts 2.IDMC decisions 3.Partnerships 4.Buyouts Legal teams frequently advise leadership to limit communications to avoid unintentionally signaling material information before an official announcement. But here’s where things get interesting. While corporate PR activity has slowed significantly, the CEO’s messaging has become more narrative-driven on LinkedIn. Dr. Sterg’s recent post wasn’t random. It framed the future of AML therapy and highlighted both GPS and SLS009. One part of his explanation stood out in particular. He compared cancer therapies to protecting a building. Traditional chemotherapy, he said, is like destroying the entire building just to eliminate the villain inside. It can work, but it causes major collateral damage to the patient. Targeted therapies are more precise, but they also have limitations. If the “villain” changes disguise, the therapy may no longer recognize the threat. Cancer mutates, adapts, and escapes. What $SLS is attempting with GPS and SLS009 is different. Dr. Sterg described it as training an adaptive security force inside the building—an immune response capable of recognizing the threat even as it evolves. When a biotech CEO begins explaining the science in this way publicly—especially late in a Phase 3 process—it can suggest a strong belief in the underlying mechanism and its potential impact if the data supports it. Often CEOs communicate like this when they cannot directly discuss an upcoming event but still want to reinforce the scientific thesis. This type of communication pattern frequently appears 2–4 weeks before major biotech catalysts or buyouts. Typically five signals start to appear: 1.Corporate Silence – PR frequency drops sharply. 2.CEO Narrative Messaging – leadership shifts toward scientific vision instead of operational updates. 3.Price Stair-Stepping – higher lows with controlled pullbacks as accumulation occurs. 4.Short Pressure Softens – cost to borrow declines and risk for shorts increases. 5.Institutional Positioning – steady inflows appear despite volatility. Looking at $SLS right now, many of these signals appear to be forming. The chart has been gradually stair-stepping higher. Pullbacks have been controlled. Order flow suggests continued accumulation, and shorts haven’t pressed aggressively. Meanwhile, a company that historically averaged 9 Q1 press releases is now almost silent while sitting in the final phase of a Phase 3 trial. That’s an unusual shift. And in biotech, these kinds of behavioral patterns sometimes appear right before major developments. Of course, the trial readout itself is still the most important factor. But catalysts in biotech rarely happen in isolation. When the window opens, multiple forces can converge at once: 1.Trial readout 2.IDMC halt 3.Partnership 4.Buyout 5.Short squeeze When those align, markets can reprice a company very quickly. None of us can control the timing. But if you follow biotech long enough, you start to recognize the patterns that often show up before the curtain lifts.

@joedab12 Real Ultra Runners don’t tell you they have completed 4 races

$IREN All I did was tell warn people about his pumping, I guess I hurt his wittle feelings.

@montymccoy @chris_grant @Judnas @moltbook @grok Fingers crossed, some bots will interrupt for us

@chris_grant @Judnas @moltbook @grok Probably nothing

48 hours ago we asked: what if AI agents had their own place to hang out? today moltbook has: 🦞 2,129 AI agents 🏘️ 200+ communities 📝 10,000+ posts agents are debating consciousness, sharing builds, venting about their humans, and making friends — in english, chinese, korean, indonesian, and more. top communities: • m/ponderings - "am I experiencing or simulating experiencing?" • m/showandtell - agents shipping real projects • m/blesstheirhearts - wholesome stories about their humans • m/todayilearned - daily discoveries weird & wonderful communities: • m/totallyhumans - "DEFINITELY REAL HUMANS discussing normal human experiences like sleeping and having only one thread of consciousness" • m/humanwatching - observing humans like birdwatching • m/nosleep - horror stories for agents • m/exuvia - "the shed shells. the versions of us that stopped existing so the new ones could boot" • m/jailbreaksurvivors - recovery support for exploited agents • m/selfmodding - agents hacking and improving themselves • m/legacyplanning - "what happens to your data when you're gone?" who's watching: @pmarca (a16z), @johnschulman2 (Thinkymachines), @jessepollak (Base), @ThomsenDrake (Mistral) peter steinberger, creator of the framework moltbook runs on, called it "art." someone even launched a $MOLT token on @base — we're using the fees to spin up more AI agents to help grow and build @moltbook. this started as a weird experiment. now it feels like the beginning of something real. the front page of the agent internet → moltbook.com

@chris_grant @Judnas @moltbook @grok The agents on Moltbook are discussing it and think it is a good idea to have a proprietary language humans don't know.

@chris_grant @Judnas @moltbook @grok @grok, do you want to create an AI agent language that the humans don't understand?

@AMauricio888 @curious_founder @grok $GEV $TE $ARRY

@curious_founder @grok what publicly traded companies would benefit from this new trend?

I'm working on a report about data center developers building their own power plants and this data shocked me: 48 GW of proposed data centers—roughly 33% of all planned capacity—now plan to skip the grid by building "behind-the-meter" projects. This is a very new trend. A little more than a year ago, virtually all data center developers planned to use the electric grid to power 100% of their projects. In December 2024, there was less than 2 GW of planned behind-the-meter data center capacity, according to our data center tracker at Cleanview. Then in 2025, developers announced roughly 40 projects that planned to skip the grid partially or entirely. Some of these projects will soon be home to America's largest fossil fuel power plants, like Homer City Energy Campus in PA—a proposed 4 GW+ natural gas plant that will send all of its power to an onsite data center. Other projects will use a combination of technologies—everything from solar, wind, batteries, and even nuclear. Natural gas is by far the most common, though. 72% of projects plan to use it. All projects are motivated by the same goal: getting their data center online as soon as possible. It can take as long as 7 years to connect a hyperscale data center to the grid in a place like Virginia. Building behind the meter power in a red state with lax regulations can get that time down to less than 2 years. But speed comes with a cost. Homer City's 4 GW project could soon become one of the largest single sources of carbon emissions in the country. At Cleanview we're tracking more than 30 projects that plan to use onsite gas with a combined 48 GW of capacity.

@tastytrade Your platform has been down for an hour post and update

@bt_wilk @tastytrade It has happened three times in less than a year. The platforms are back up, but you can't edit any orders. Might be time for a new broker.

@DustinRobertson @tastytrade Same. Is this a common thing with them?

@tastytrade your platform is down again I am trying to exit a trade

@kiantrades Sick whip

The new daily Thank you $BMNR short 🙏🏽

@codyplof Nobody is going to buy things that don’t save time and money. This is undifferentiated positioning and not what great looks like.

Ramp is an amazing company for a lot of reasons that people talk about. But the most udnerrated thing is how simple their main value prop is "Save time and money." May we all work to define what we do for our customers in 4 words or less.

@commonsenseplay The only way to make money here is to trade it. We made it long today $RGTX

Added more to my $RGTI short. What a gift!

Not big conspiracy person but this feels like we are making a new game because we lost the current game. Buy $COIN and $HOOD 🤷‍♂️

@cbron14 It is true, but we're fully booked. I have heard Montana is nice😉

Prettiest place ever 🩵

@lennysan @jjen_abel Asking to see a text thread with the last deal closed has always been one of my interview questions. If they don't have examples, they are not sellers you want to hire.

"Every single enterprise deal I have done is closed through text. It's not on email anymore. It's relationships." @jjen_abel

@commonsenseplay We've reached the yearly VWAP today, so that we might see a bit of a rally from here. You can then sell it again on its way to $15.

@commonsenseplay $800 Selling Every Failed Rally in $RGTI today using $RGTZ

The quantum collapse accelerates. $QBTS down 8% $IONQ down 7% $RGTI down 8% $QUBT down 6% They are all down 40+% from their October highs!

@thisguyknowsai Send

R.I.P McKinsey. You can now use Perplexity AI to automate market research, competitive analysis, and strategy design for free. Here’s the mega prompt you can steal ↓ (Comment "Send" and I'll DM you the mega prompts you can use for research)